Amid global tumult, U.S. stocks down modesty ahead of

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
Amid global tumult, U.S. stocks down modesty ahead of open
Adam Shell, USA TODAY 6:46 a.m. EST February 9, 2016
GTY 509076132 A MAX USA NY

(Photo: Andrew Renneisen, Getty Images)
2 CONNECTTWEETLINKEDINCOMMENTEMAILMORE

Tumult in global stock markets continued overnight with Japanese shares falling more than 5%, but stocks on Wall Street are holding up better after yesterday's rout and despite rising angst, sporting modest losses in pre-market trading.

Global investors are experiencing high anxiety as the horrific start to 2016 continues. There has been a flight from risky assets, such as stocks, as investor worries mount over a myriad of risks, including slowing global growth, a steep decline in oil prices, uncertainty over interest rate policy in the U.S. and, more recently, concern over the health of banks, mainly in Europe.

Monday's wild ride on Wall Street, when the Dow Jones industrial average cut a 401 point loss in half to finish down 178 points, spread to Asia. The Nikkei 225 in Japan tumbled 5.4% and, in a sign of rising risk aversion, the yield on Japan's 10-year government bond fell into negative territory at -0.023%. A negative yield means investors earn no interest on their investment, but instead pay the government to keep their cash safe. Stocks also finished nearly 3% lower in Australia.

In pre-market trading around 6:45 a.m. ET, the Dow was down about 50 points and the Standard & Poor's 500 was off 6 points.

In Europe, which suffered sizable losses across the board yesterday, shares were holding steady, with losses relatively tame in a volatile session Tuesday. The broad Stoxx Europe 600 was down 0.3%. The German DAX was off 0.1% and the CAC 40 in Paris was down 0.4%.

The persistent selling is adding up to sizable losses on Wall Street early in the new year. Heading into Tuesday's trading session the Dow was down 8% in 2016, the S&P 500 was off 3.2% and the Nasdaq was 14.5% lower.

And the declines from last year's record closing highs are even bigger. The Nasdaq composite is down 17.9% from its July record, and flirting with a bear market, defined as a decline of 20% or more. Both the Dow and S&P 500 remain firmly in correction territory, as they are both down more than 19% from their May 2015 peaks. The Dow is off 12.5% from its peak and the S&P is down 13%.

The paper losses are adding up, too. The Wilshire 5000 Total Market Index has lost $2.6 trillion in market value so far this year after falling 10.6%.

Investors fear a negative feedback loop from the combination of big losses in the oil patch and slowing economic growth around the globe. Wall Street is now starting to price in a recession in the U.S., despite the fact that economists are still placing a relatively low probability of a recession striking.

Wall Street pros say asset prices got inflated from the Federal Reserve's zero interest rate policy and money printing that occurred to get the economy back on its feet following the 2008 financial crisis. Now, with the Fed at the start of an interest rate hike cycle, some of the air is coming out of investments that became overvalued.

Investors worry that rate hikes from the Fed this year will cause the current market turbulence and economic slowdown to worsen. That is why Wall Street pros will be closely watching Fed chair Janet Yellen's two-day testimony to Congress beginning Wednesday for any signs that the Fed, which has said it plans on gradual hikes this year, will pare back its earlier calls for four quarter-point hikes totaling 1% this year.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CMO Joins ARTHEx: Boosting Innovative RNA Focus

Updated Category News Views 26

ARTHEx Biotech's Strategic Expansion Looks like ARTHEx Biotech is shaking things up with some strategic moves by bringing in Dr. Christian Freitag as their new Chief Medical Officer. Now, if you’re knee-deep in the biotech game, you'll know that having someone like Freitag onboard is akin to adding a star player to your lineup. The guy's got more than two decades of...

Continue Reading
Zinzino's October Sales Report: Eye on the Nutritional Prize

Updated Category News Views 38

Delving Into Zinzino's October Performance Alright, let’s cut to the chase and dive headfirst into what really matters—Zinzino AB’s preliminary sales report for October 2026. If you’re banking on the thriving nutritional supplement sector, this Swedish company’s numbers might just be your radar’s blip. October wasn’t just any month for these folks; it was a...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Starting Pet End-of-Life Talks: Why Timing Matters

Updated Category News Views 23

Early Conversations Can Change Everything The minute you bring it up, let's be honest, nobody likes to talk about end-of-life decisions, not even for their pets. Yet, when you think about it, biding your time until things get critical isn't doing anyone any favors, especially not the furry ones. Drs. Brandon and Paola Beebout, two piercing minds from Kearney, Nebraska,...

Continue Reading
Kendra Scott's 'Long Live Joy' Campaign Dazzles

Updated Category News Views 40

Unveiling a Holiday Spectacle: 'Long Live Joy' Party hats off, folks, because Kendra Scott is stepping up the holiday game with something they’re calling 'Long Live Joy'. Now, we're not just talking about any run-of-the-mill marketing fluff. This one’s big, it’s colorful, and it’s here to make your accessorized holidays a tad more enchanting. The Multi-Faceted...

Continue Reading
RideNow Gears Up for Earnings Amidst Industry Shifts

Updated Category News Views 185

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Continue Reading
Duolingo Faces Class Action: Investors React Strongly

Updated Category News Views 63

Duolingo's Rough Road: A Lawsuit in Motion Alright, fasten your seatbelts, because we've got a real rollercoaster here with Duolingo (NASDAQ: DUOL). You know, the language-learning app that's been pushing ads like it's going out of style? Well, investors are seeing red—not the kind you want, either. This class action lawsuit looming over them is like an unwelcome...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 81

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Baidu Faces Fraud Allegations: What Investors Should Know

Updated Category News Views 196

Trouble on the Horizon for Baidu Shareholders If you've got a pulse in the world of stock trading, you've likely caught wind of the storm brewing over at Baidu, Inc. (NASDAQ: BIDU). We're talking some heavy-duty allegations of securities fraud, and a class action lawsuit that's got investors scrutinizing their portfolios like never before. The lawsuit's been filed in the...

Continue Reading
AllianceBernstein Unveils Income-Focused ETF Amid Volatile Times

Updated Category News Views 40

Diving into AllianceBernstein's New Income ETF Well, today we’ve got something stirring in the financial waters over at AllianceBernstein. They’ve launched a new exchange-traded fund (ETF), aptly named the AB Equity Premium Income ETF [INK]. Now, if you’re wondering what’s cooking with this newcomer on the NASDAQ, let’s crack it open and see what’s under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Keyo Elevates Rudy Dajie to CEO, Driving Innovative Payments

Updated Category News Views 237

Keyo Appoints Rudy Dajie as New CEO for Advanced Payment Solutions Keyo has recently announced a game-changing leadership appointment with Rudy Dajie stepping into the role of Chief Executive Officer. In a world where artificial intelligence is rapidly evolving, the demand for enhanced security in biometric identification is greater than ever. Innovative Biometric...

Continue Reading
Final Call for $XPL Token Access: Join the XploraDEX Journey

Updated Category News Views 162

Final Chance to Participate in $XPL Token Distribution The $XPL token distribution is entering its crucial final phase, marking an exciting moment for both investors and traders. As the presale of XploraDEX nears its closing date, many are eager to grab their share of the tokens before the opportunity slips away. This innovative platform, set on the XRP Ledger, has the...

Continue Reading
Promising Small-Cap Stocks on the Rise for Investors

Updated Category News Views 73

Small-Cap Stocks on the Verge of Growth As 2024 progresses, many analysts have identified a resurgence in small-cap stocks, suggesting that this year could mark a turning point for these often-overlooked companies. With the economic landscape shifting, especially as interest rates stabilize, there is renewed hope for sectors that faced challenges in previous years....

Continue Reading
Eli Lilly's New Oral Diabetes Treatment Python Results Exceed Expectations

Updated Category News Views 204

Eli Lilly's Groundbreaking Diabetes Treatment Trials Eli Lilly and Company (NYSE: LLY) has made significant advancements in the treatment of type 2 diabetes with their oral medication, orforglipron. Recent Phase 3 trials, ACHIEVE-2 and ACHIEVE-5, have demonstrated impressive results in controlling blood sugar levels among participants. ACHIEVE Trials Overview The...

Continue Reading
Experience Luxury and Performance with the 2025 LC 500 Convertible

Updated Category News Views 63

Introducing the 2025 LC 500 Convertible The 2025 LC 500 Convertible marks another exciting development in the luxury automobile market, maintaining its prestige and allure. This model has undergone a few updates and is ready to impress enthusiasts and casual drivers alike. Standout Features of the 2025 Model This year's model comes with notable enhancements, including...

Continue Reading